Accéder au contenu
Merck

Sonic vibration ameliorates inflammatory diseases via the up-regulation of IL-10.

Animal cells and systems (2024-04-30)
Huijeong Ahn, Eui-Man Jung, Min-Woo Cho, Meoung-Geun Shin, Jae-Yeong Choi, Geun-Shik Lee
RÉSUMÉ

Sonic vibration (SV), or vibroacoustic therapy, is applied to enhance local and systemic blood circulation and alleviate pain using low-frequency sine wave vibrations. However, there is limited scientific data on the mechanisms through which the benefits are achieved. In this study, we investigated the impact of SV on inflammatory responses by assessing cytokine secretion in both in vivo and in vitro models. After inducing inflammatory responses in mice and macrophages, we studied cytokine expression and the symptoms of inflammatory diseases in response to three frequencies (14, 45, or 90 Hz) of SV stimulation at 0.5 m/s2 of amplitude. The results showed that SV at 90 Hz significantly increased interelukin-10 (IL-10) secretion in mice who were administered lipopolysaccharides (LPS) and increased the expression of IL-10 transcripts in peritoneal exudate cells and macrophages. Furthermore, SV at 90 Hz improved LPS-induced lethality and alleviated symptoms in a colitis model. In conclusion, this study scientifically proves the anti-inflammatory effects of vibration therapy through its ability to increase IL-10 expression.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Bay 11-7082, ≥98% (HPLC), powder
Sigma-Aldrich
SB 203580, InSolution, ≥98%, 1 mg/ml, reversible inhibitor of p38 MAP kinase